Timing of Delivery in Fetal Growth Restriction of Uncomplicated Women
Completed · Not applicable
Conditions studied: Fetal Growth Restriction
In brief
The goal of the study is to determine whether labor induction at 37 weeks of pregnancy can improve the baby's health at birth when compared with delivery at a later point in the pregnancy.
Key facts
- Study ID
- NCT03046355
- Run by
- The University of Texas Health Science Center, Houston
- People needed
- 21
- Starts
- 2017-03-13
- Expected to finish
- 2019-03-18
- Last updated by the study team
- 2019-06-13
Who can join
Age: 18 and older, up to 39. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Singleton pregnancy
- Gestational age 34 weeks 0 days to 37 weeks 0 days at time of enrollment
- Dating of pregnancy by last menstrual period consistent with an ultrasound, ultrasound <21 weeks and 6 days of gestation, or known date of conception in the setting of in vitro fertilization
- No known major anomalies (anomalies requiring surgery antenatally or in the neonatal period, anomalies not compatible with life as determined by the physician)
- FGR defined as estimated fetal weight (EFW) < 10th percentile by Hadlock formula with normal umbilical artery Doppler studies and normal amniotic fluid
You may not qualify if…
- Known major fetal anomalies
- Multiple gestation or selective reduction of multiple gestation after 14 weeks
- Previous stillbirth at term
- Indications for delivery at <39 weeks. Common examples include:
- Placenta previa
- Placenta accreta
- Vasa previa
- History of classical cesarean section or myomectomy
- Human immunodeficiency virus (HIV)
- Oligohydramnios (low amniotic fluid, defined as maximum vertical pocket <2.0cm)
- High-risk pregnancy as determined by the physician. Common examples include:
- Pre-gestational diabetes or gestational diabetes on medication
- Chronic hypertension on medication
- Maternal cardiac disease
- Asthma requiring oral steroids during pregnancy
- Chronic renal disease
- Antiphospholipid syndrome
- Hyperthyroidism
- Prior stillbirth
- Systemic lupus erythematous
- Hemoglobinopathies such as sickle cell disease
Where it is running
- Memorial Hermann Memorial City Medical Center — Houston, Texas, United States
- The University of Texas Health Science Center at Houston — Houston, Texas, United States
- Bellaire - Memorial Hermann — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.